Evidence map›Paper›PMID 34940318›Full record

ReviewGels (Basel, Switzerland)2021

Novel Trends in the Development of Surfactant-Based Hydraulic Fracturing Fluids: A Review.

Andrey V Shibaev, Andrei A Osiptsov, Olga E Philippova

Abstract readReview
In one paragraph

Review in Gels (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Andrey V ShibaevPhysics Department, Moscow State University, 119991 Moscow, Russia.ORCID 0000-0002-3019-5764
Andrei A OsiptsovSkolkovo Institute of Science and Technology (Skoltech), 121205 Moscow, Russia.
Olga E PhilippovaPhysics Department, Moscow State University, 119991 Moscow, Russia.ORCID 0000-0002-1098-0255

Funding

Russian Science Foundation 21-73-30013
6 · The paper itself

Abstract

Viscoelastic surfactants (VES) are amphiphilic molecules which self-assemble into long polymer-like aggregates-wormlike micelles. Such micellar chains form an entangled network, imparting high viscosity and viscoelasticity to aqueous solutions. VES are currently attracting great attention as the main components of clean hydraulic fracturing fluids used for enhanced oil recovery (EOR). Fracturing fluids consist of proppant particles suspended in a viscoelastic medium. They are pumped into a wellbore under high pressure to create fractures, through which the oil can flow into the well. Polymer gels have been used most often for fracturing operations; however, VES solutions are advantageous as they usually require no breakers other than reservoir hydrocarbons to be cleaned from the well. Many attempts have recently been made to improve the viscoelastic properties, temperature, and salt resistance of VES fluids to make them a cost-effective alternative to polymer gels. This review aims at describing the novel concepts and advancements in the fundamental science of VES-based fracturing fluids reported in the last few years, which have not yet been widely industrially implemented, but are significant for prospective future applications. Recent achievements, reviewed in this paper, include the use of oligomeric surfactants, surfactant mixtures, hybrid nanoparticle/VES, or polymer/VES fluids. The advantages and limitations of the different VES fluids are discussed. The fundamental reasons for the different ways of improvement of VES performance for fracturing are described.

Indexed as

clean fracturing fluidsgelshydraulic fracturingnanoparticle/VES fluidsoil recoveryoligomeric surfactantspolymer/VES fluidsresponsiveness to hydrocarbonsviscoelasticityviscoelastic surfactantswormlike micelles

Identifiers

PMID34940318
PMCPMC8701209

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.